RecruitingPhase 2NCT06503172

Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level

The Clinical Effectiveness of Taiwanese Whole Grain Job's Tear on Muscle Health, Blood Glucose and Lipid Levels- a Randomized Controlled Trial


Sponsor

Taipei Veterans General Hospital, Taiwan

Enrollment

80 participants

Start Date

Jun 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Background: This investigation aims to explore efficacy of Taiwanese whole grain job's tear on muscle health and blood glucose and lipid levels in community-dwelling older adults. Methods: An open-label, 16-week, randomized controlled, cross-over trial involving participants with subject complaint of slower gait or weakness or fall in last year were recruited. The intervention group consumed Taiwanese whole grain job's tear (red job's tear) or white job's tear. Assessments included laboratory tests, functional assessments, and body composition.


Eligibility

Min Age: 60 YearsMax Age: 95 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Taiwanese whole grain job's tear (red job's tear) and a biological treatment called White job's tear for people with frailty, hyperglycemia, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALTaiwanese whole grain job's tear (red job's tear)

300cc drink made from red job's tear, 2 bottle/day from week 0 to week 8

BIOLOGICALWhite job's tear

300cc drink made from white job's tear, 2 bottle/day from week 0 to week 8


Locations(1)

Taipei Veterans General hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06503172


Related Trials